BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 53 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $166,000 | +58.1% | 22,374 | 0.0% | 0.12% | +12.4% |
| Q1 2020 | $105,000 | -59.3% | 22,374 | -88.8% | 0.10% | -30.9% |
| Q4 2019 | $258,000 | +24.0% | 199,791 | +0.8% | 0.15% | +16.0% |
| Q3 2019 | $208,000 | -8.4% | 198,291 | +48.8% | 0.13% | -9.7% |
| Q2 2019 | $227,000 | -38.6% | 133,282 | +21.4% | 0.14% | -42.9% |
| Q1 2019 | $370,000 | +15.3% | 109,832 | 0.0% | 0.25% | +0.8% |
| Q4 2018 | $321,000 | -52.5% | 109,832 | 0.0% | 0.25% | -43.8% |
| Q3 2018 | $676,000 | -10.9% | 109,832 | +6.8% | 0.45% | -21.3% |
| Q2 2018 | $759,000 | +63.6% | 102,832 | +45.2% | 0.57% | +16.4% |
| Q1 2018 | $464,000 | -14.7% | 70,814 | +9.6% | 0.49% | -14.5% |
| Q4 2017 | $544,000 | – | 64,614 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |